IVAX Diagnostics, Inc. Reports Q4 EPS of $(0.03)

IVAX Diagnostics, Inc. IVD reports its financial results for the fourth quarter and full year ended December 31, 2010. For the quarter ended December 31, 2010, net revenue was $4.0 million compared with $4.5 million in the quarter ended December 31, 2009. Gross profit for the quarter ended December 31, 2010 was $1.9 million compared with $2.4 million in the quarter ended December 31, 2009. Gross profit margins for the quarter ended December 31, 2010 were 46.3% compared with 54.3% in the quarter ended December 31, 2009. Loss from operations for the quarter ended December 31, 2010 was $0.9 million compared with a loss from operations of $1.2 million in the quarter ended December 31, 2009. Net loss for the quarter ended December 31, 2010 was $0.8 million, or $0.03 loss per share, compared to net loss of $1.3 million, or $0.05 loss per share, in the quarter ended December 31, 2009.